The 2023 Country 2 Country 4 Cancer ride organised by Bristol Myers Squibb will feature more than 90 of the company's employees cycling in five European countries from 1-18th September in support of the Union for International Cancer Control (UICC) and selected members to raise funds with the aim of accelerating the fight against cancer and facilitating a better life for cancer patients.
For the 8th year, the 2023 edition of the Country 2 Country 4 Cancer (C2C4C) ride will feature more than 90 Bristol Myers Squibb employees riding in Germany, Switzerland, France, Spain and the United Kingdom for nearly 2,200 kilometres from 1-18 September.
The 18-day event involves six teams each cycling a three-day segment. This year we celebrate 10 years of C2C4C and riding for patients, with the inaugural event taking place in the United States in 2014.
Since 2016, nearly 550 Bristol Myers Squibb employees in Europe have raised more USD2.6 million through the C2C4C ride.
In this 2023 edition, six teams will feature riders participating from 19 countries including Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom, the United States and for the first time, participants from the Czech Republic, Hungary, Poland and Romania. The goal of C2C4C is to raise awareness for cancer research and European cancer organisations who are members of UICC.
The participants are novice riders who have committed themselves to 5 months of intensive training to complete their portion of the ride. Some are cancer survivors, others have witnessed the devastating impact of cancer on friends and family. All are dedicated Bristol Myers Squibb employees who are riding to help raise funds to fight against cancer by supporting European cancer organisations, who are members of UICC.
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Cancer is among the leading causes of death worldwide. Each year, there are 18.1 million new cases and 9.6 million cancer-related deaths worldwide, and these numbers are growing.
This is why Bristol Myers Squibb has chosen to support the UICC and its members in their mission to reduce the global cancer burden and integrate cancer control into the world health and development agenda.
Encourage your colleagues, families and friends to donate, as cancer affects us all. Each team rides and raises funds for members of the Union for International Cancer Control.
Click on the charity of your country below to support and donate to a local cancer patient organisation. Donations are open as of 5 June 2023.
Sept. 1-3 2023
Munich, Germany to Boudry, Switzerland
Initiative Krebskranke Kinder München e.V.
Sept. 4-6 2023
Italy, Switzerland & Austria
Boudry, Switzerland to Nimes, France
Italy: Women Against Lung Cancer in Europe (WALCE)
Switzerland & Austria: CanSearCH
Sept. 7-9 2023
Denmark, Finland, Norway & Sweden
Nimes, France to Girona, Espagne
Finland: Association of Cancer Patients in Finland
Norway: AKTIV Mot Kreft
Sept. 10-12 2023
Spain & Portugal
Girona, Espagne to Toulouse, France
Asociación Española Contra el Cáncer
Sept. 13-15 2023
Toulouse France to Paris
Sept. 16-18 2023
UK & Ireland
Netherlands & Belgium
Paris, France to Uxbridge, UK
UK-Ireland: Maggie's Cancer Centres and The Irish Cancer Society
Netherlands: Villa Joep
Belgium: Belgium Foundation Against Cancer
Riders in multiple segments
Asociatia Daruieste Viata / Give Life Association
Share this page